Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)

Authors Shen Y, Huang S, Kang J, Lin J, Lai K, Sun Y, Xiao W, Yang L, Yao W, Cai S, Huang K, Wen F

Received 19 June 2017

Accepted for publication 10 November 2017

Published 30 January 2018 Volume 2018:13 Pages 399—407

DOI https://doi.org/10.2147/COPD.S144312

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Charles Downs

Peer reviewer comments 2

Editor who approved publication: Professor Chunxue Bai


Yongchun Shen,1 Shaoguang Huang,2 Jian Kang,3 Jiangtao Lin,4 Kefang Lai,5 Yongchang Sun,6 Wei Xiao,7 Lan Yang,8 Wanzhen Yao,6 Shaoxi Cai,9 Kewu Huang,10 Fuqiang Wen1

1Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu, 2Department of Pulmonary Disease, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, 3Department of Respiratory Medicine, Institute of Respiratory Diseases, The First Affiliated Hospital of China Medical University, Shenyang, 4Department of Respiratory Diseases, China-Japan Friendship Hospital, Beijing, 5State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 6Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 7Department of Respiratory Medicine, Qilu Hospital of Shandong University, Jinan, 8Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 9Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 10Division of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China

Abstract: Airway mucus hypersecretion is one of the most important characteristics of chronic airway inflammatory diseases. Evaluating and managing airway mucus hypersecretion is of great importance for patients with chronic airway inflammatory diseases. This consensus statement describes the pathogenesis, clinical features, and the management of airway mucus hypersecretion in patients with chronic airway inflammatory diseases in the People’s Republic of China. The statement has been written particularly for respiratory researchers, pulmonary physicians, and patients.

Keywords: mucus, COPD, asthma, bronchiectasis, cystic fibrosis, treatment

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]